Aadi Bioscience Conference: CEO Spotlights Whitehawk ADC Pipeline, Cash Runway Through 2028 [Yahoo! Finance]
Whitehawk Therapeutics, Inc. (WHWK)
Company Research
Source: Yahoo! Finance
million in cash at the end of the prior year's Q3, which management says provides a runway into 2028. The company is building “better ADCs” using high-affinity/attenuated-Fc targeting, a paired-chain carbon-bonded bioconjugation/linker design with PEG masking and a proprietary Topo-1 payload, and reports nonclinical advantages of ~3–10x tumor potency, 5–25x improved stability, and a 2–3x safety margin versus average Topo-1 ADCs. Three clinical programs are advancing: HWK-007 (PTK7) and HWK-016 (MUC16) are enrolling in phase I dose-escalation studies, HWK-206 (biparatopic SEZ6) is expected to file an IND by mid-year with a phase I start in Q3, and the company anticipates clinical readouts in H1 2027 plus additional preclinical data in spring 2026. Interested in Aadi Bioscience, Inc.? Here are five stocks we like better. Whitehawk Therapeutics CEO Dave Lennon outlined the company's antibody-drug conjugate (ADC) strategy and pipeline during an Annual Healthcare Conference present
Show less
Read more
Impact Snapshot
Event Time:
WHWK
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
WHWK alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
WHWK alerts
High impacting Whitehawk Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
WHWK
News
- Whitehawk Therapeutics Reports Fourth Quarter and Full-Year 2025 Financial Results and Recent Highlights [Yahoo! Finance]Yahoo! Finance
- Whitehawk Therapeutics Reports Fourth Quarter and Full-Year 2025 Financial Results and Recent HighlightsPR Newswire
- Aadi Bioscience Conference: Whitehawk Unveils 3-Program ADC Pipeline, Targets First Data in 2027 [Yahoo! Finance]Yahoo! Finance
- Whitehawk Therapeutics to Participate in Upcoming Investor Conferences [Yahoo! Finance]Yahoo! Finance
- Whitehawk Therapeutics to Participate in Upcoming Investor ConferencesPR Newswire